· BATS · USD · Data as of 2026-07-30
AUM
—
Expense ratio
—
Yield
—
YTD return
—
Last price
$234.40
Commodity · Coverage 13% · low
Today
21.5
Outlook
45.1
Block A (composite-derived)
55.5
Block C (market behavior)
1.1
Today overlay (Block D)
0.0
Outlook overlay (Block D)
0.0
today_score = clip(0,100, 50 + 0.15·(A−50) + 0.60·(C−50) + D_today). Block B (holdings rollup) is in Phase 3 development; β=0 caps the natural range at ~12.5–87.5 in Preview v0.9. Formula version tide-etf-v1.0.0.
55.5
Coverage 13% · low
Liquidity
—
Expenses
—
Performance
—
Volatility
55.5
Dividend
—
Concentration
—
Smart Money
—
Activist
—
Formula version composite-v1.0.0. Axes hover to see why a sub-score is missing.
Editorial coverage for ARKC is coming soon — copy is rolling out to the broader universe ETF-by-ETF in 2026Q2.
Ark Genomic Revolution Trust is an exchange-traded fund (ETF) that focuses on investments in the genomic fusion of healthcare and technology. Its primary function is to provide exposure to companies that are spearheading innovative approaches within the genomic sector. These companies work in areas such as DNA sequencing, bioinformatics, molecular diagnostics, and agricultural biology. The trust selects its holdings with a keen emphasis on emerging technologies that hold the potential to revolutionize healthcare by improving treatments and advancing precision medicine. As such, it plays a significant role in the biotechnology and healthcare sectors, often featuring companies involved in cutting-edge research and development. Managed by Ark Investment Management, the trust is part of a family of ETFs that aim to capitalize on disruptive innovation trends across various industries. Its presence in the financial market underscores the growing investor interest in next-generation biotech solutions, offering a diversified vehicle for those seeking to engage with the rapidly evolving dynamics of genomics and related fields.
Net AUM change history is not yet available for this ETF. Fund-flow time series is a Phase B deliverable.
Current AUM: —. AUM change is computed from rolling daily fundamentals snapshots; it reflects total net-asset deltas (creations/redemptions + market value moves), not pure share creations.
Fund documents (fact sheets, prospectuses, semi-annual reports) for ARKC are coming soon. The BW fund-document archive will surface PDFs alongside a metadata index for searchability.